Formic Acid

Formic Acid

SCHEMBL5459686

Nc1nc(C(F)(F)F)nc2nc[nH]c12.O=CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.50
GDA Q9Y2T3 1/20 0.50
PI4KA P42356 2/20 0.44
PI4K2B Q8TCG2 2/20 0.44
PI4K2A Q9BTU6 2/20 0.44
PI4KB Q9UBF8 2/20 0.44
LMNA P02545 1/20 0.44
DRD3 P35462 1/20 0.44
XDH P47989 1/20 0.44
LRRK2 Q5S007 1/20 0.44
CDK2 P24941 1/20 0.41
DPP4 P27487 1/20 0.41
PNP P00491 1/20 0.40
KDR P35968 1/20 0.38
AURKB Q96GD4 1/20 0.38
POLA1 P09884 1/20 0.36
BRAF P15056 1/20 0.36
MGMT P16455 1/20 0.35
MAP3K5 Q99683 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1233712 0.91 PDPK1 (0.59) PDPK1GDAPI4KAPI4K2BPI4K2A
Formic Acid SCHEMBL5459681 0.77 PDE4A (0.33) GDA
SCHEMBL3136203 0.74 CDK2 (0.40) PDPK1GDAXDHCDK2DPP4
SCHEMBL887132 0.72 PDPK1 (0.51) PDPK1GDAPI4KAPI4K2BPI4K2A
SCHEMBL4534389 0.71 CDK2 (0.40) PDPK1GDAXDHCDK2DPP4
SCHEMBL27987389 0.71 PDPK1 (0.59) PDPK1GDAPI4KAPI4K2BPI4K2A
SCHEMBL3137199 0.71 DPP4 (0.56) PDPK1GDAXDHCDK2DPP4
SCHEMBL28164496 0.69 PDPK1 (0.51) PDPK1GDAPI4KAPI4K2BPI4K2A
Isoguanine SCHEMBL887741 0.69 PDPK1 (0.66) PDPK1GDAPI4KAPI4K2BPI4K2A
Isoguanine SCHEMBL29569323 0.69 PDPK1 (0.66) PDPK1GDAPI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225303-A1 8-Oxoadenine Compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-09-27 US disclosed
EP-1728792-A1 8-OXOADENINE COMPOUND Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225303-A1 8-Oxoadenine Compound TLR7, CCR8, TLR8 PDPK1 3190/4885GDA 808/4885PI4KA 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.